VYNE Therapeutics Inc.

Q3 2023 13F Holders

Symbol: VYNE
CUSIP: 92941V308
Type: Equity
Class: COM
Num filings: 21
Total reported value, excl. options: $1.45 M

Compare 2023 Q3 to

Manager	Report Date	Value ($000)	Shares	Option Type